Trexquant Investment LP Has $479,000 Stock Position in Medifast Inc $MED

Key Points

• Trexquant Investment LP reduced its stake in Medifast Inc by 39.0% in the first quarter, holding 35,537 shares worth approximately $479,000 after selling 22,767 shares.
• Medifast recently reported $0.04 earnings per share, surpassing the consensus estimate of ($0.22), with revenues of $105.56 million exceeding expectations of $96.10 million.
• Institutional investors and hedge funds collectively own 95.51% of Medifast's stock, indicating strong institutional interest in the company.

Trexquant Investment LP reduced its holdings in Medifast Inc (NYSE:MED - Free Report) by 39.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,537 shares of the specialty retailer's stock after selling 22,767 shares during the quarter. Trexquant Investment LP owned approximately 0.32% of Medifast worth $479,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. Charles Schwab Investment Management Inc. grew its position in Medifast by 132.7% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 265,572 shares of the specialty retailer's stock worth $3,580,000 after acquiring an additional 151,434 shares during the last quarter. Two Sigma Investments LP boosted its position in Medifast by 11.4% in the 4th quarter. Two Sigma Investments LP now owns 232,069 shares of the specialty retailer's stock valued at $4,089,000 after buying an additional 23,822 shares during the last quarter. Two Sigma Advisers LP boosted its position in Medifast by 86.0% in the 4th quarter. Two Sigma Advisers LP now owns 216,000 shares of the specialty retailer's stock valued at $3,806,000 after buying an additional 99,900 shares during the last quarter. Northern Trust Corp boosted its position in Medifast by 0.9% in the 4th quarter. Northern Trust Corp now owns 101,775 shares of the specialty retailer's stock valued at $1,793,000 after buying an additional 871 shares during the last quarter. Finally, Peapod Lane Capital LLC bought a new position in Medifast in the 1st quarter valued at $933,000. 95.51% of the stock is currently owned by institutional investors.

Medifast Stock Performance

MED traded up $0.06 during mid-day trading on Friday, reaching $13.98. The stock had a trading volume of 121,015 shares, compared to its average volume of 152,266. Medifast Inc has a 52 week low of $11.57 and a 52 week high of $21.98. The stock has a market capitalization of $153.63 million, a P/E ratio of 43.69 and a beta of 0.82. The firm's fifty day simple moving average is $13.91 and its two-hundred day simple moving average is $13.61.

Medifast (NYSE:MED - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The specialty retailer reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.26. Medifast had a return on equity of 2.00% and a net margin of 0.76%.The business had revenue of $105.56 million for the quarter, compared to analyst estimates of $96.10 million. Medifast has set its Q3 2025 guidance at -0.600-0.00 EPS. As a group, analysts expect that Medifast Inc will post 0.51 EPS for the current fiscal year.

Medifast Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.